Literature DB >> 18164130

Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury.

Chanhee Park1, Ik-Hyun Cho, Donghoon Kim, Eun-Kyeong Jo, Se-Young Choi, Seog Bae Oh, Kyoungpyo Park, Joong Soo Kim, Sung Joong Lee.   

Abstract

Traumatic brain injury is accompanied by glial cell activation around the site of the injury. In this study, we investigated the role of toll-like receptor 2 (TLR2) in glial cell activation using a stab-wound injury (SWI) model with TLR2 knock-out mice. Penetration of a normal mouse brain with a 26-G needle using a stereotaxic instrument resulted in an 18- and 4-fold upregulation of GFAP and CD11b mRNA, respectively, along the needle track in the injury area. However, in the TLR2 knock-out mice, the induced expression of these genes was reduced by 70% and 40%, respectively. Likewise, there was a reduction in the area of activated glial cells detected by immunohistochemistry and the glial cells had a less-activated morphology in the TLR2 knock-out mice. In addition, the expression of the heme oxygenase-1 (HO-1) gene, a glia-expressing wound-responsive gene, was reduced after SWI in TLR2 knock-out mice. Taken together, these data argue that TLR2 contributes to the glial cell activation and HO-1 gene expression associated with traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164130     DOI: 10.1016/j.neulet.2007.11.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death.

Authors:  Jinpyo Hong; Ik-Hyun Cho; Kyung Il Kwak; Eun Cheng Suh; Jinsoo Seo; Hyun Jung Min; Se-Young Choi; Chong-Hyun Kim; Seung Hwa Park; Eun-Kyeong Jo; Soojin Lee; Kyung Eun Lee; Sung Joong Lee
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

Review 3.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

Review 4.  New advances on glial activation in health and disease.

Authors:  Kim Mai Lee; Andrew G MacLean
Journal:  World J Virol       Date:  2015-05-12

5.  Genome-Wide Changes in Peripheral Gene Expression following Sports-Related Concussion.

Authors:  Kian Merchant-Borna; Hyunhwa Lee; Dan Wang; Viktoria Bogner; Martijn van Griensven; Jessica Gill; Jeffrey J Bazarian
Journal:  J Neurotrauma       Date:  2016-04-01       Impact factor: 5.269

6.  Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation.

Authors:  Fiona M Inglis; Kim M Lee; Kevin B Chiu; Olivia M Purcell; Peter J Didier; Kasi Russell-Lodrigue; Scott C Weaver; Chad J Roy; Andrew G MacLean
Journal:  J Neurovirol       Date:  2015-09-29       Impact factor: 2.643

Review 7.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

8.  Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury.

Authors:  Sarah Claire Hellewell; Maria Cristina Morganti-Kossmann
Journal:  Mediators Inflamm       Date:  2012-06-04       Impact factor: 4.711

9.  Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model.

Authors:  Xin-Yi Cao; Xiao Qian; Guo-Dong Liu; Yu-Hai Wang
Journal:  Curr Med Sci       Date:  2021-05-28

10.  Haemopexin affects iron distribution and ferritin expression in mouse brain.

Authors:  Noemi Morello; Elisabetta Tonoli; Federica Logrand; Veronica Fiorito; Sharmila Fagoonee; Emilia Turco; Lorenzo Silengo; Alessandro Vercelli; Fiorella Altruda; Emanuela Tolosano
Journal:  J Cell Mol Med       Date:  2009-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.